超越诊断的韧性:抑郁症中优于预期结局的前瞻性神经相关因素
本研究将韧性定义为相对于22个风险与保护变量累积风险而言「优于预期」的抑郁症状严重程度,在N=1804名参与者中采用岭回归预测症状并取残差作为韧性指标。结果显示累积风险解释了T1期49.6%和T2期40.1%的症状方差,韧性残差具有中度时间稳定性;T1期韧性未与脑形态相关,但T1期较高韧性预测T2期左侧眶额下回和颞极灰质体积较低。
要点
- 韧性定义为相对于累积风险而言优于预期的抑郁症状严重程度。
- T1期韧性未发现与脑形态学指标相关。
- T1期较高韧性预测T2期左侧眶额下回和颞极灰质体积较低。
核心结论
- 以优于预期抑郁症状严重程度定义的韧性未与即时脑结构差异相关。
- 前瞻性分析显示较高韧性预测左侧眶额下回和颞极灰质体积随时间减小。
- 作者提出该灰质体积减小可能反映更高神经效率或延迟的生物学代价。
研究设计与样本
- 前瞻性磁共振成像研究,数据来自Marburg-Münster情感障碍队列研究。
- 共纳入N=1804名参与者(955名健康,849名抑郁),随访分析N=808。
- 采用岭正则化回归基于22个风险与保护变量预测抑郁症状严重程度,以残差作为韧性指标。
- 补充进行韧性(优于预期结局)与脆弱(劣于预期结局)个体的极端组比较。
主要发现
- 累积风险在T1期解释抑郁症状方差的49.6%,在T2期解释40.1%。
- 韧性残差评分显示中度时间稳定性(r=0.32,p<0.001)。
- 感兴趣区与全脑分析未发现T1期韧性相关的形态学关联。
- T1期较高韧性预测T2期左侧眶额下回和颞极灰质体积较低(ROI,pFWE(peak)<0.001,rpartial=0.18)。
- 未发现皮质厚度变化。
关键数值与推荐
- 韧性操作化为相对于22个风险与保护变量累积风险而言优于预期的汉密尔顿抑郁量表症状严重程度。
- T1期较高韧性预测T2期左侧眶额下回和颞极灰质体积较低,ROI分析pFWE(peak)<0.001,rpartial=0.18。
临床怎么用
- 提示韧性并非与即时脑结构差异同步,临床评估韧性时需考虑时间维度。
- 眶额下回和颞极灰质体积变化可能作为韧性相关长期神经适应的候选标志物。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Resilience, the ability to adapt positively in the face of adversity, is shaped by combined influences of risk and protective factors. Previous neuroimaging studies on resilience have predominantly focused on single factors, often operationalizing resilience dichotomously as the absence of psychiatric disorders despite adversity. In this prospective magnetic resonance imaging study, we defined resilience as "better-than-expected" depressive symptom severity (Hamilton Depression Rating Scale) relative to cumulative risk across 22 risk and protective variables. Using ridge-regularized regression in N = 1804 participants (955 healthy, 849 depressed) from the Marburg-Münster Affective Disorders Cohort Study, we predicted symptom severity and derived residuals as measures of resilience. Residuals were then used to predict gray matter volume (GMV) and cortical thickness at baseline (T1) and two-year follow-up (T2; N = 808). This approach was complemented by extreme-group comparisons of resilient (better-than-expected outcome) and vulnerable (worse-than-expected outcome) individuals. Cumulative risk explained 49.6% of variance in depressive symptoms at T1 and 40.1% at T2. Residual scores showed moderate temporal stability (r = 0.32, p < 0.001). Region-of-interest and whole-brain analyses revealed no morphometric associations with resilience at T1. In contrast, higher resilience at T1 predicted lower GMV in the left inferior orbitofrontal gyrus (IOFG) and temporal pole at T2 (ROI, pFWE(peak)<0.001, rpartial = 0.18), with no changes in cortical thickness. Taken together, resilience to cumulative risk, defined as better-than-expected depressive symptom severity, was not associated with immediate brain structural differences. However, prospective analyses revealed smaller GMV in the IOFG and temporal pole over time, potentially reflecting greater neural efficiency or delayed biological costs.
引用
- Hammes V, Brosch K, Usemann P, et al. Resilience beyond diagnosis: prospective neural correlates of better-than-expected outcomes in depression. Mol Psychiatry. 2026. PMID: 42778581. doi:10.1038/s41380-026-03897-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。